Literature DB >> 3545888

A small-gauge cannula device for continuous infusion of exogenous agents into the brain.

L R Williams, H L Vahlsing, T Lindamood, S Varon, F H Gage, M Manthorpe.   

Abstract

A method is described for the construction of an intraventricular or intraparenchymal cannula device, which when connected to an Alzet osmotic pump, can be used for the continuous infusion of experimental solutions into the brain. A 33-gauge, stainless-steel cannula is encased within a dental acrylic stabilization platform prior to stereotaxic implantation, and after implantation, the platform is glued to the animal's skull using cyanoacrylate adhesive. This procedure provides for the long-term stability (at least 4 weeks) of the small-gauge cannula without the need for additional stabilization skull screws, thus minimizing damage to surrounding tissues by the cannula and postsurgical trauma to the animal. Using the stock model 2002 Alzet pump to infuse artificial cerebral spinal fluid at a flow rate equal to 0.5 microliter/h, an inflammatory tissue reaction around the cannula tip was consistently found after 2 weeks of continuous intraparenchymal infusion. However, the inflammatory reaction could be significantly reduced or eliminated by decreasing the flow rate to approximately 0.25 microliter/h, using a modified Alzet pump. Alternatively, the stock 0.5 microliter/h pump could be used without causing parenchymal damage if the cannula tip was implanted into the lateral ventricle.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3545888     DOI: 10.1016/0014-4886(87)90313-x

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  9 in total

1.  Construction and implantation of a microinfusion system for sustained delivery of neuroactive agents.

Authors:  Miles G Cunningham; Ryan P O'Connor; Sydney E Wong
Journal:  J Vis Exp       Date:  2008-03-17       Impact factor: 1.355

2.  Endogenous FGF-2 is important for cholinergic sprouting in the denervated hippocampus.

Authors:  A M Fagan; S T Suhr; C A Lucidi-Phillipi; D A Peterson; D M Holtzman; F H Gage
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

3.  Regulation of NGF and NT-3 protein expression in peripheral targets by sympathetic input.

Authors:  Chris L Randolph; Michael A Bierl; Lori G Isaacson
Journal:  Brain Res       Date:  2007-02-01       Impact factor: 3.252

4.  Ciliary neurotrophic factor prevents retrograde neuronal death in the adult central nervous system.

Authors:  R E Clatterbuck; D L Price; V E Koliatsos
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

5.  Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain.

Authors:  Santiago E Farias; Mireille Basselin; Lisa Chang; Kim A Heidenreich; Stanley I Rapoport; Robert C Murphy
Journal:  J Lipid Res       Date:  2008-05-23       Impact factor: 5.922

6.  Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation.

Authors:  Mireille Basselin; Hyung-Wook Kim; Mei Chen; Kaizong Ma; Stanley I Rapoport; Robert C Murphy; Santiago E Farias
Journal:  J Lipid Res       Date:  2009-12-29       Impact factor: 5.922

7.  Characterization of trkB immunoreactive cells in the intermediolateral cell column of the rat spinal cord.

Authors:  Annemarie M McCartney; Vanessa L Abejuela; Lori G Isaacson
Journal:  Neurosci Lett       Date:  2008-05-21       Impact factor: 3.046

Review 8.  Microdialysis and microperfusion electrodes in neurologic disease monitoring.

Authors:  Luke A Stangler; Abbas Kouzani; Kevin E Bennet; Ludovic Dumee; Michael Berk; Gregory A Worrell; Steven Steele; Terence C Burns; Charles L Howe
Journal:  Fluids Barriers CNS       Date:  2021-12-01

9.  Intracerebroventricular administration of nerve growth factor induces gliogenesis in sensory ganglia, dorsal root, and within the dorsal root entry zone.

Authors:  Johannes C M Schlachetzki; Donald P Pizzo; Debbi A Morrissette; Jürgen Winkler
Journal:  Biomed Res Int       Date:  2014-03-16       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.